News

Novacyt Group is an AIM listed international diagnostics company focused on providing innovative solutions for clinical diagnostics and molecular testing. Headquartered in the United Kingdom and listed on AIM, the company develops, manufactures, and supplies a broad portfolio of diagnostic products and services to healthcare providers, laboratories, and research institutions worldwide.

The Company’s strategy is centred on delivering high-quality diagnostic technologies that support disease detection, monitoring, and prevention, while continuing to expand its presence across key global healthcare markets through innovation and operational excellence.

Publication of Annual Report

The Perivan shareholder communications team was delighted to be appointed to support the re-design, printing and mailing of their latest Annual Report, which included the provision of the Engage data room platform, utilised for secure proof distribution and stakeholder review. The Report was successfully published and posted to shareholders on 11th June 2026.

Perivan is the UK’s leading designer and producer of annual reports. For further information, click here.